PHARMACY

Asda to sell cancer drugs on ‘not-for-profit’ basis

BY Alaric DeArment

LEEDS, U.K. A retailer in the United Kingdom said Thursday it would become the first to sell cancer drugs to customers at cost.

Asda, one of the country’s largest retailers and a division of Walmart, said it would sell the drugs on a “not-for-profit” basis. For example, AstraZeneca’s lung cancer drug Iressa (gefitinib) will sell for $3,112.73, compared with prices ranging from more than $3,734.92 to $4,671.97 at other retailers, based on present currency exchange rates.

“The crippling cost of paying privately for cancer treatments has forced many people to spend their savings or even re-mortgage their house to pay for these essential drugs,” Asda superintendent pharmacist John Evans said. “We are the first retailer to recognize this injustice and to do something about it, and we are calling on other retailers to follow our lead.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

MinuteClinic opens two Mass. locations

BY Antoinette Alexander

WOONSOCKET, R.I. MinuteClinic, which is owned by CVS Caremark, has expanded its Massachusetts-based clinics to 20 with Wednesday’s opening of two new locations in Hanover and Quincy.

 

"Since opening our first store-based clinic in Massachusetts in 2008, we have helped to expand access to high-quality, convenient and affordable care to thousands of residents who have visited us at convenient CVS/pharmacy locations near where they live and work," stated Andrew Sussman, president of MinuteClinic and SVP/associate chief medical officer of CVS Caremark. "We are committed to working with the medical community in Massachusetts to build on the state’s precedent-setting efforts to broaden access to quality health services."

 

 

According to MinuteClinic, it has had more than 50,000 patient visits in Massachusetts (not including flu shot visits) in less than two years. About 70% of the patients seen at MinuteClinic locations in Massachusetts do not identify a primary care provider. MinuteClinic offers those patients without a primary care provider information on nearby practices accepting new patients.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Hospira extends acquisition offer to Javelin

BY Alaric DeArment

LAKE FOREST, Ill. Hospira has extended its $145 million offer to buy Javelin Pharmaceuticals, the generic drug maker said Wednesday.

The offer, originally made in April, was set to expire at the end of Tuesday, but will now expire at the end of June 2.

Hospira said Javelin had not satisfied all the conditions for acquisition, which Javelin said was due to a supply-chain problem with the painkiller Dyloject in the United Kingdom, though Javelin expressed disagreement with Hospira’s position.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?